| View |
|
BRP-100-01
|
Epoetin Alfa
|
Epoguard
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd
|
China
|
-
|
29 March 2022
|
14 December 2026
|
| View |
|
BRP-100-02
|
Epoetin Alfa
|
Eporife
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
17 September 2022
|
14 December 2026
|
| View |
|
BRP-100-03
|
Epoetin Alfa
|
Epoeden
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
-
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
31 January 2023
|
14 December 2026
|
| View |
|
BRP-100-04
|
Epoetin Alfa
|
Epolitt
|
4,000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
31 May 2023
|
14 December 2026
|
| View |
|
BRP-100-05
|
Epoetin Alfa
|
Ematep
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
12 July 2023
|
14 December 2026
|
| View |
|
BRP-100-06
|
Epoetin Alfa
|
Eprohab
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
21 July 2023
|
14 December 2026
|
| View |
|
BRP-100-07
|
Epoetin Alfa
|
Eprosenz
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
21 July 2023
|
14 December 2026
|
| View |
|
BRP-100-08
|
Epoetin Alfa
|
Epotine
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
02 November 2023
|
14 December 2026
|
| View |
|
BRP-100-09
|
Epoetin Alfa
|
Eprotex
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
08 December 2023
|
14 December 2026
|
| View |
|
BRP-100-10
|
Epoetin Alfa
|
Aepotin
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
03 February 2024
|
14 December 2026
|
| View |
|
BRP-100-11
|
Epoetin Alfa
|
None
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
15 February 2024
|
14 December 2026
|
| View |
|
BRP-100-12
|
Epoetin Alfa
|
Epson 4000IU
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Antianemic Preparations
|
Shenyang Sunshine Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
20 July 2024
|
14 December 2026
|
| View |
|
BRP-101
|
Epoetin Alfa
|
Epokine
|
4,000 IU/mL
|
Solution for Injection (IV/SC)
|
-
|
HK inno.N Corporation
|
Korea
|
-
|
07 January 2022
|
20 October 2026
|
| View |
|
BRP-102
|
Epoetin Alfa (Recombinant Human Erythropoietin)
|
Epokine
|
10,000 IU/mL
|
Solution for Injection (IV/SC)
|
HEMATOPOIETIC GROWTH FACTOR
|
HK inno.N Corporation
|
Korea
|
Renewal
|
23 November 2022
|
24 January 2028
|
| View |
|
BRP-103
|
EPOETIN ALFA (RECOMBINANT HUMAN ERYTHROPOIETIN)
|
EPOKINE
|
4,000 IU/ 0.4 mL
|
SOLUTION FOR INJECTION (IV/SC)
|
HEMATOPOIETIC GROWTH FACTOR
|
HK inno.N CORPORATION
|
KOREA
|
Renewal
|
08 July 2022
|
25 July 2027
|
| View |
|
BRP-103-01
|
Epoetin Alfa (Recombinant Human Erythropoietin)
|
Epokor
|
4,000 IU/0.4 mL
|
Solution for Injection (IV/SC)
|
HEMATOPOIETIC GROWTH FACTOR
|
HK Inno.N Corporation
|
Korea
|
CLIDP Conversion
|
29 July 2022
|
25 July 2027
|
| View |
|
BRP-104
|
EPOETIN ALFA (RECOMBINANT HUMAN ERYTHROPOIETIN)
|
EPOKINE
|
2,000 IU/ 0.5 mL
|
SOLUTION FOR INJECTION (IV/SC)
|
HEMATOPOIETIC GROWTH FACTOR
|
HK inno.N CORPORATION
|
KOREA
|
Renewal
|
08 July 2022
|
25 July 2027
|
| View |
|
BRP-105
|
Epoetin Alfa
|
Eposis
|
4000IU/0.4mL
|
Solution For Injection (I.V/S.C)
|
Antianemics
|
Daewong Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
04 April 2022
|
07 May 2027
|
| View |
|
BRP-106
|
Botulinum Toxin Type A
|
Beautem
|
100 Units
|
Powder for Solution for Injection (IM/SC)
|
Muscle Relaxants, Peripherally Acting Agents
|
Daewoong Pharmaceutical Co., Ltd.
|
Korea
|
Initial
|
07 March 2022
|
07 March 2027
|
| View |
|
BRP-108
|
Pegfilgrastim
|
Pelgraz
|
6mg/0.6mL
|
Solution For Injection (SC)
|
-
|
Intas Pharmaceuticals Ltd. (Biopharma Division)
|
India
|
Initial
|
07 June 2022
|
07 June 2027
|